Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
1Martin Henkes, 2Heiko kinkalicious van der Kuip, 1Walter E Aulitzky12nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Auerbachstr.110, Stuttgart, Germany; 2Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstr.112, Stuttgart, and University of Tuebingen, GermanyAbstract: Treatment options for